CVE-2014-0560

Use-after-free vulnerability in Adobe Reader and Acrobat 10.x before 10.1.12 and 11.x before 11.0.09 on Windows and OS X allows attackers to execute arbitrary code via unspecified vectors.

View on NVD

Severity

N/A

EPSS

Probability of exploitation (next 30 days): 0.1306 (13.1%)

Percentile: 94.1%

EPSS: 2026-05-06

Affects

adobe:acrobat_readerapple:mac_os_xmicrosoft:windowsadobe:acrobat

Technical description

Use-after-free vulnerability in Adobe Reader and Acrobat 10.x before 10.1.12 and 11.x before 11.0.09 on Windows and OS X allows attackers to execute arbitrary code via unspecified vectors.

Published: 9/17/2014, 10:55:06 AM

Last modified: 5/6/2026, 10:30:45 PM

References

How to read this card

Actively exploited

KEV (Known Exploited Vulnerabilities) is CISA's catalog of CVEs confirmed as actively exploited in the real world. If a CVE is on KEV, someone is already using it in attacks.

CVSS 10.0

CVSS 10.0 — máxima severidad teórica. Explotable de forma remota, sin privilegios, con impacto total. Aún no confirmada como explotada en el mundo real, pero parchea ya.

AI-recommended

Un modelo de lenguaje revisó el CVE y consideró que afecta a software ampliamente desplegado o herramientas comunes de desarrollo. Un humano del equipo aprobó la publicación antes de que llegara aquí.

Categorías de impacto que evalúa la IA

widely_deployed_infra — kernel Linux, OpenSSL, glibc, k8s, Docker, nginx, OpenSSH.

popular_dev_tooling — Node.js, Python, Go, React, Next.js, librerías comunes de npm/pip.

common_consumer_software — Chrome, Firefox, Windows, macOS, apps móviles populares.

enterprise_saas — GitHub, GitLab, Atlassian, Salesforce, Cisco, Fortinet, Ivanti.

niche_software — CMS regionales, herramientas de hobby, librerías de poco uso.

not_relevant — firmware específico de proveedor, software descontinuado.

EPSS — EPSS (Exploit Prediction Scoring System) by FIRST.org estimates the probability that a CVE will be exploited in the next 30 days. Range is 0 to 1; very fresh CVEs typically score low until evidence accumulates.